Page last updated: 2024-08-26

sr141716 and Hepatitis

sr141716 has been researched along with Hepatitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Hassan, R; Mahmoud, MF; Rezq, S	1

Other Studies

1 other study(ies) available for sr141716 and Hepatitis

Article	Year
Rimonabant ameliorates hepatic ischemia/reperfusion injury in rats: Involvement of autophagy via modulating ERK- and PI3K/AKT-mTOR pathways. International immunopharmacology, 2021, Volume: 100 Topics: Animals; Autophagy; Autophagy-Related Proteins; Cannabinoid Receptor Antagonists; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Hepatitis; Inflammation Mediators; Lipid Peroxidation; Liver; Liver Cirrhosis; Male; Oxidative Stress; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Rats, Wistar; Receptor, Cannabinoid, CB1; Reperfusion Injury; Rimonabant; Signal Transduction; TOR Serine-Threonine Kinases	2021

Article

Year

Rimonabant ameliorates hepatic ischemia/reperfusion injury in rats: Involvement of autophagy via modulating ERK- and PI3K/AKT-mTOR pathways.

International immunopharmacology, 2021, Volume: 100

Topics: Animals; Autophagy; Autophagy-Related Proteins; Cannabinoid Receptor Antagonists; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Hepatitis; Inflammation Mediators; Lipid Peroxidation; Liver; Liver Cirrhosis; Male; Oxidative Stress; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Rats, Wistar; Receptor, Cannabinoid, CB1; Reperfusion Injury; Rimonabant; Signal Transduction; TOR Serine-Threonine Kinases

2021